Advertisement

Topics

Reply!, Inc. Company Profile

22:06 EDT 25th September 2017 | BioPortfolio

Reply.com is the leading online marketing platform for the acquisition of locally-targeted and category-specific consumers on a cost-per-click or cost-per-lead basis. By eliminating the need for complex and expensive online marketing infrastructures and large teams of experts, Reply.com makes Internet marketing available to businesses of all sizes. Reply! provides a highly-profitable alternative to online marketing solutions offered by major search engines and ad networks. To learn more about Reply!, visit www.reply.com.


News Articles [93 Associated News Articles listed on BioPortfolio]

Adjustment Strategies in Studies of Therapy—Reply

In Reply Dr Karp raises concerns about the way we explained several statistical concepts to a wide audience of practicing clinicians.

Global Burden of Disease Attributable to Hypertension—Reply

In Reply Dr Cooper and colleagues suggest that coronary heart disease remains infrequent to rare in sub-Saharan Africa and Asia. We disagree. The empirical evidence behind their claim is unclear as th...

Behavioral Economics and Health Insurance Reform—Reply

In Reply Dr Colloff correctly points out that moving high-cost patients from private exchanges to Medicare would save money immediately for the federal government, but potentially at the expense of ho...

Risks of Medical Metaphors—Reply

In Reply In my article, I advocated for expanding the scope of the evidence-based paradigm to include physician-patient communication, focusing on the role of metaphors. I argued that the same rigorou...

Hemoglobin A 1c as a Surrogate for Clinical Outcomes in Diabetes Studies—Reply

In Reply We agree with Dr Venker that HbA1c levels were not the same in the placebo and active treatment groups of the EMPA-REG OUTCOME and LEADER trials and appreciate his careful analysis of HbA1c l...

Managing Conflicts of Interest in Practice Guidelines Panels—Reply

In Reply It is encouraging to see the growing interest in avoiding COI on practice guidelines panels. The RIGHT checklist is a step in the right direction.

Survival After Laparoscopic vs Abdominal Hysterectomy—Reply

In Reply Drs Yin and Tian comment on the potential differential effect of total laparoscopic hysterectomy between different levels of BMI. Notwithstanding speculation regarding the reasons total lapar...

Nonclinical Factors Affecting Shared Decision Making—Reply

In Reply We agree with Drs Smith and Volk that shared decision making should include discussions about the social and economic burdens of care associated with different treatment options. A multidisci...

Drugs and Medications [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication

The aim of this study is to assess the benefits from the AAISafeR/SafeR algorithm of Symphony 2550 or REPLY DR in a wide range of pacemaker patients. The expected benefits will be a resul...

Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry.

This study is collecting data on quality of life, (care)needs and socio-economic factors in colorectal (ex-)cancer patients via a written questionnaire completed by the patient him/herself...

Pharmacist Follow-up, a Qualitative Study of Patient Experience

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from h...

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Recent studies have shown the importance of preserving spontaneous atrio-ventricular conduction in patients implanted with an implantable cardiac pacemaker. The SafeR/AAISafeR pacing mode...

Companies [4 Associated Companies listed on BioPortfolio]

Reply!, Inc.

Reply.com is the leading online marketing platform for the acquisition of locally-targeted and category-specific consumers on a cost-per-click or cost-per-lead basis. By eliminating the need for compl...

AusPharmList.NET.AU

The last month's posts to AusPharmList are displayed below with the most recent at the top of the page. For a complete list of all posts to AusPharmList in 2005, click here. This web page is interacti...

Encryptics

Encryptics is a pioneering provider of data-protection services that take a life cycle approach to data management, security and compliance. The company’s easy-to-use service...

QuickTestPrep.com

Have you ever wanted to PASS the Pharmacy Technician Certification Exam? Suppose you could...Attend live interactive classes taught by a pharmacist preceptor. If you have any questions, you may contac...

More Information about "Reply!, Inc." on BioPortfolio

We have published hundreds of Reply!, Inc. news stories on BioPortfolio along with dozens of Reply!, Inc. Clinical Trials and PubMed Articles about Reply!, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reply!, Inc. Companies in our database. You can also find out about relevant Reply!, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record